-
Mashup Score: 14
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 10
Gilead Sciences Announces First Quarter 2024 Financial Results
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6Gilead Sciences, Inc. - 10 day(s) ago
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6Gilead Sciences, Inc. - 10 day(s) ago
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 5Gilead Sciences, Inc. - 14 day(s) ago
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 8Partnerships and Community | Gilead - 1 month(s) ago
Learn more about our partnerships with community organizations to help address health challenges and barriers to care around the world.
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 8FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six - 1 month(s) ago
FDA Expands Indication for Gilead’s Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 8Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program - 1 month(s) ago
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 15Gilead Sciences Announces Completion of Acquisition of CymaBay - 1 month(s) ago
Gilead Sciences Announces Completion of Acquisition of CymaBay
Source: www.gilead.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 12Biktarvy® Demonstrates High Rates of Viral Suppression in People With HIV and Comorbidities - 2 month(s) ago
Biktarvy® Demonstrates High Rates of Viral Suppression in People With HIV and Comorbidities
Source: www.gilead.comCategories: General Medicine News, PayerTweet
#GileadNews: The U.S. FDA has approved an updated label for an #HIV treatment to include data on use in pregnant people with HIV who are virologically suppressed. This advances our efforts to address the needs of underrepresented communities in research. https://t.co/pnnEipdsTA https://t.co/u8kk6P0aAt